Emmanouil S. Brilakis, MD, PhD, FACC, FAHA, FESC, FSCAI

Use of the CrossBoss/Stingray devices for CTO PCI is associated with equally high success and equally low complication rates as other techniques, both immediately post procedure and during long-term follow-up, in spite of its use in higher...

Use of the CrossBoss/Stingray...

10/30/2013

Journal of Invasive Cardiology

Video

Incidence, Treatment, and Outcomes of Coronary Artery Perforation During PCI

11/07/2022

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

Deepak L. Bhatt , MD, MPH, FACC, FAHA, FESC, MSCAI;

Deepak Bhatt, MD, MPH, Editor-in-Chief of the Journal of Invasive Cardiology (JIC), and Emmanouil Brilakis, MD, PhD, discuss coronary perforation, a rare but potentially life-threatening complication of PCI.

Deepak Bhatt, MD, MPH,...

11/07/2022

Journal of Invasive Cardiology

Clinical Images

Unstable Angina Due to Stent Fracture

08/01/2008

Calin Maniu , MD;

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

Gregory W. Barsness , MD;

Michael Wahl , MD;

Case Report. A 78-year-old woman who had undergone coronary artery bypass grafting eight years earlier presented with unstable angina. At coronary angiography, an aorto-ostial lesion was found in a saphenous vein graft to the right posterior...

Case Report. A 78-year-old woman...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Effect of Extended-Release Niacin on Saphenous Vein Graft Atherosclerosis: Insights from the Atherosclerosis Lesion Progression Intervention Using Niacin Extended Release in Saphenous Vein Grafts (ALPINE-SVG) Pilot Trial

10/01/2015

Anna P. Kotsia , MD, PhD;

Georgios Christopoulos , MD;

James A. de Lemos , MD;

Darren K. McGuire , MD, MHSc;

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

Milton Packer , MD;

Subhash Banerjee , MD, FSCAI;

Daisha J. Cipher , PhD, MD;

Michele Roesle , RN, BSN, MD;

Bavana V. Rangan , BDS, MPH, MD;

Ameka Coleman , MS, BS;

Intermediate SVG lesions have high rates of progression. The purpose of this study was to examine the impact of extended-release niacin (ER-niacin) vs. placebo on intermediate saphenous vein graft (SVG) lesions.

Intermediate SVG lesions have...

10/01/2015

Journal of Invasive Cardiology

Original Contribution

Impact of Chronic Total Occlusions on Revascularization Scores and Outcome Prediction

03/15/2017

Dimitrios Karmpaliotis , MD, PhD;

Roxana Mehran , MD;

Ajay J. Kirtane , MD, SM;

Bjorn Redfors , MD, PhD;

Philippe Généreux , MD;

Girma Minalu Ayele , PhD;

Dominic P. Francese , MPH;

Adriano Caixeta , MD, PhD;

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

Gregg W. Stone , MD, FACC, FSCAI;

This study evaluates the contribution of chronic total occlusion (CTO)-related SYNTAX score (SS) to the overall SS for patients with CTO and compares the traditional SS to a simplified variant.

This study evaluates the...

03/15/2017

Journal of Invasive Cardiology

Original Contribution

Lesion Complexity and Procedural Outcomes Associated With Ostial Chronic Total Occlusions: Insights From the PROGRESS-CTO Registry

07/13/2023

Yader Sandoval , MD;

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

Judit Karacsonyi , MD, PhD;

Michalis Koutouzis , MD, PhD;

Dimitrios Karmpaliotis , MD, PhD;

Bavana V. Rangan , BDS, MPH, MD;

Basem Elbarouni , MD;

Farouc A. Jaffer , MD, PhD;

Ehtisham Mahmud , MD;

Athanasios Rempakos , MD;

Mitul P. Patel , MD;

Bahadir Simsek , MD;

M. Nicholas Burke , MD;

Spyridon Kostantinis , MD;

Jaikirshan J. Khatri , MD;

Omer Goktekin , MD;

Salman S. Allana , MD;

Khaldoon Alaswad , MD;

Paul Poommipanit , MD, FACC, FSCAI;

Wissam A. Jaber , MD;

Sevket Gorgulu , MD;

William J. Nicholson , MD;

Stéphane Rinfret , MD, SM;

Oleg Krestyaninov , MD;

Dmitrii Khelimskii , MD;

Nidal Abi Rafeh , MD;

Ahmed M. ElGuindy , MD, MSc, FRCP;

Ioannis Tsiafoutis , MD;

We examined the clinical and angiographic characteristics and procedural outcomes of 8,788 CTO PCIs performed at 35 US and non-US centers between 2012 and 2022. In-hospital major adverse cardiac events (MACE) included death, myocardial...

We examined the clinical and...

07/13/2023

Journal of Invasive Cardiology

Original Contribution

Procedural and In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Interventions in Patients With Acute Myocardial Infarction: Insights From a Prospective Multicenter International Registry

09/01/2021

Evangelia Vemmou , MD;

Ilias Nikolakopoulos , MD;

Jaikirshan J. Khatri , MD;

Ioannis Tsiafoutis , MD;

Khaldoon Alaswad , MD;

Michalis Koutouzis , MD, PhD;

Omer Goktekin , MD;

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

Pouyan Arman , MD;

Ankur Gupta , MD, DM, PhD;

Paul B. Poomipanit , MD;

Farouc A. Jaffer , MD, PhD;

James W. Choi , MD;

Farshad Forouzandeh , MD, PhD;

Mir Babar Basir , MD, DO;

Judit Karacsonyi , MD, PhD;

Nidal Abi Rafeh , MD;

Ehtisham Mahmud , MD;

Ahmed M. ElGuindy , MD, MSc, FRCP;

Mitul P. Patel , MD;

We assessed the clinical and procedural characteristics, technical success, procedural success, and in-hospital outcomes of 2314 patients who underwent CTO-PCI at 20 experienced centers between 2012 and 2017, classified according to whether...

We assessed the clinical and...

09/01/2021

Journal of Invasive Cardiology

Letter from the Editor

Use of the DyeVert System in Chronic Total Occlusion Percutaneous Coronary Intervention

08/27/2019

Yale Wang , MD;

Iosif Xenogiannis , MD;

Ivan Chavez , MD;

Mario Gössl , MD, PhD;

Allison Hall , MD;

Anil Poulose , MD;

Peter Tajti , MD;

M. Nicholas Burke , MD;

Michael R. Mooney , MD;

Paul Sorajja , MD;

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

Bavana V. Rangan , BDS, MPH, MD;

Evangelia Vemmou , MD;

Imre Ungi , MD, PhD;

Ilias Nikolakopoulos , MD;

Pamela Morley , RN;

Santiago Garcia , MD;

CTO-PCI often requires administration of large contrast volume. The DyeVert system (Osprey Medical, Inc) is a device that interfaces with standard manifold systems to reduce the amount of contrast used. We compared the procedural outcomes of...

CTO-PCI often requires...

08/27/2019

Journal of Invasive Cardiology

Vascular Disease

Crossing of Infrainguinal Peripheral Arterial Chronic Total Occlusion With a Blunt Microdissection Catheter

08/05/2014

Atif Mohammad , MD;

Karan Sarode , MS, MA;

Andrew J.P. Klein , MD, FACC, FSCAI;

M. Ishtiaque Ali , MD;

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

Rahul Thomas , MD;

Subhash Banerjee , MD, FSCAI;

Salil Sethi , MD;

Mazen S. Abu-Fadel , MD;

Mirza S. Baig , MD;

Anand Prasad , MD, FACC, FSCAI, RPVI;

Osvaldo S. Gigliotti , MD;

Nicolas W. Shammas , MD, MS, FACC, FSCAI, FACP, FSVM;

Crossing of lower-extremity arterial chronic total occlusion (CTO) can be challenging. This study examines the use of the Viance peripheral CTO crossing device (Covidien) in the superficial femoral, popliteal, and below-the knee arterial...

Crossing of lower-extremity...

08/05/2014

Journal of Invasive Cardiology